Disorders of glucose transport, not elsewhere classified
ICD-10 E74.81 is a billable code used to indicate a diagnosis of disorders of glucose transport, not elsewhere classified.
Disorders of glucose transport encompass a range of metabolic conditions characterized by impaired glucose uptake and utilization by cells. These disorders can arise from various underlying mechanisms, including genetic mutations affecting glucose transport proteins, enzyme deficiencies, or other metabolic dysfunctions. Patients may present with symptoms such as hypoglycemia, hyperglycemia, or metabolic acidosis, depending on the specific disorder and its severity. The clinical manifestations can vary widely, from mild symptoms to severe metabolic crises. Diagnosis typically involves biochemical testing, genetic screening, and sometimes muscle or skin biopsy to assess glucose transport activity. Management strategies may include dietary modifications, enzyme replacement therapy, or pharmacological interventions aimed at improving glucose metabolism. Given the complexity of these disorders, a multidisciplinary approach involving endocrinologists, geneticists, and dietitians is often necessary for optimal patient care.
Detailed clinical history, laboratory results, and treatment plans must be documented.
Patients presenting with unexplained hypoglycemia or hyperglycemia.
Endocrinologists should ensure that all relevant metabolic tests are documented to support the diagnosis.
Genetic testing results and family history must be included.
Patients with a family history of metabolic disorders or unexplained metabolic symptoms.
Geneticists should document the specific mutations identified to support the diagnosis.
Used to confirm glucose levels in patients suspected of having glucose transport disorders.
Document the reason for testing and any relevant clinical history.
Endocrinologists should ensure that glucose testing is linked to the diagnosis.
Common symptoms include hypoglycemia, hyperglycemia, fatigue, and metabolic acidosis, which can vary based on the specific disorder.
Diagnosis typically involves biochemical testing, genetic screening, and sometimes muscle or skin biopsy to assess glucose transport activity.
Accurate coding is crucial for appropriate treatment, management, and reimbursement, as well as for tracking the prevalence of these disorders.
